Jinhai Medical Technology's stock plummeted 5.12% during intraday trading on Monday, reflecting investor concerns over the company's financial health.

The decline follows analysis highlighting Jinhai Medical Technology's challenging financial position. The company reported a net loss of SGD 17.08 million for the fiscal year 2025, despite generating sales of SGD 46.28 million. Furthermore, the company has experienced increased losses over the past five years and remains unprofitable with a negative return on equity of -33.48%.

While the company maintains a strong cash position with more cash than total debt and sufficient short-term assets to cover liabilities, the persistent unprofitability and declining earnings appear to have weighed on investor sentiment during the trading session.